National Cancer Institute   US National Institutes of Health | www.cancer.gov
US National Institutes of Health www.cancer.gov
BCSC
Breast Cancer Surveillance Consortium: Working together to advance breast cancer research
 
Home   |   Data   |   Statistics   |   Tools   |   Collaborations   |   Work with Us   |   Publications   |   About   |   Links

Performance Measures for 3,884,059 Screening Mammography Examinations1 from 1996 to 2006 by Age --- based on BCSC data as of 2008

You are viewing the 2008 collection of this data. Data from other times are also available:
Sensitivity2 Specificity3 PPV4 Recall5
Total 81.2% 91.2% 4.4% 9.0%
Age 40-44 71.9% 89.1% 1.5% 10.9%
Age 45-49 76.0% 89.6% 2.4% 10.5%
Age 50-54 79.7% 90.8% 3.4% 9.4%
Age 55-59 82.6% 91.5% 4.7% 8.8%
Age 60-64 80.8% 92.0% 5.5% 8.4%
Age 65-69 83.4% 92.5% 6.5% 7.9%
Age 70-74 83.9% 93.1% 8.0% 7.3%
Age 75-89 85.1% 93.6% 10.0% 6.9%

1 Screening mammography examinations: Mammography examinations indicated by the radiologist to be for screening with bilateral routine views done and no other mammogram within the last 9 months among women without breast implants or a prior mastectomy or a prior breast cancer diagnosis.

2 Sensitivity = The percentage of cancers§ that had a positive interpretation&.

3 Specificity = The percentage of non-cancers~ that had a negative interpretation#.

4 PPV (Positive Predictive Value) = The percentage of examinations with a positive interpretation& that result in a tissue diagnosis of cancer§.

5 Recall = The percentage of examinations with a positive interpretation&.

§ Cancers = Examinations with a tissue diagnosis of ductal carcinoma in situ or invasive cancer within one year and before the next screening mammography examination.

~ Non-cancers = Examinations without a tissue diagnosis of cancer within one year or before the next screening examination, whichever occurs earlier.

& Positive interpretation = BI-RADS category 4, 5, or 0 --- 3 with a recommendation for immediate follow-up were recoded as 0.

# Negative interpretation = BI-RADS category 1, 2, or 3 with no recommendation for immediate follow-up.

* Table numbers last updated March 31, 2009. The following source must be cited when reproducing this table: NCI-funded Breast Cancer Surveillance Consortium co-operative agreement (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040). Downloaded xx/xx/xxxx from the Breast Cancer Surveillance Consortium Web site - http://breastscreening.cancer.gov/statistics/performance/screening/2008/perf_age.html .

[Return to Screening Performance]


National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal Maintained by the Applied Research Program,
Division of Cancer Control and Population Sciences